Huons Global Co., Ltd. (KOSDAQ:084110)

South Korea flag South Korea · Delayed Price · Currency is KRW
67,500
-700 (-1.03%)
At close: Mar 20, 2026
Market Cap823.70B +90.5%
Revenue (ttm)825.44B +1.8%
Net Income24.39B -33.2%
EPS1,999.54 -33.0%
Shares Out12.20M
PE Ratio33.76
Forward PEn/a
Dividend880.00 (1.29%)
Ex-Dividend DateApr 2, 2026
Volume43,558
Average Volume79,173
Open68,400
Previous Close68,200
Day's Range65,600 - 69,700
52-Week Range35,750 - 76,700
Beta1.12
RSI56.53
Earnings DateMay 14, 2026

About Huons Global

Huons Global Co., Ltd. manufactures and sells pharmaceutical products for human health in South Korea and internationally. The company offers oral solid form products in the areas of circulatory system, metabolic, anti-pyretic analgesic anti-inflammatory, musculoskeletal system, digestive system, antihistamine, respiratory system, antibiotic, well-being, urogenital system, other chemotherapeutic, and others; and injections in the areas of anesthetic, antipyretic, analgesic, anti-inflammatory, skeletal muscle relaxant, antispasmodic, antihistami... [Read more]

Sector Healthcare
Founded 1965
Employees 118
Stock Exchange KOSDAQ
Ticker Symbol 084110
Full Company Profile

Financial Performance

In 2024, Huons Global's revenue was 813.46 billion, an increase of 7.26% compared to the previous year's 758.38 billion. Earnings were 25.79 billion, a decrease of -32.81%.

Financial Statements